Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Depreciation & Amortization (CF): 2013-2019

Historic Depreciation & Amortization (CF) for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to $490,000.

  • Soleno Therapeutics' Depreciation & Amortization (CF) changed negligibly% to $490,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $2.0 million, marking a year-over-year decrease of 0.25%. This contributed to the annual value of $2.0 million for FY2024, which is 1.48% up from last year.
  • According to the latest figures from Q4 2019, Soleno Therapeutics' Depreciation & Amortization (CF) is $490,000, which was down 0.00% from $490,000 recorded in Q3 2019.
  • Soleno Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $582,000 for Q4 2017, and its period low was -$44,000 during Q3 2016.
  • For the 3-year period, Soleno Therapeutics' Depreciation & Amortization (CF) averaged around $461,000, with its median value being $490,000 (2019).
  • In the last 5 years, Soleno Therapeutics' Depreciation & Amortization (CF) slumped by 257.14% in 2016 and then spiked by 3,193.72% in 2017.
  • Soleno Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $49,228 in 2015, then tumbled by 64.11% to $17,670 in 2016, then soared by 3,193.72% to $582,000 in 2017, then dropped by 15.81% to $490,000 in 2018, then remained steady at $490,000 in 2019.
  • Its Depreciation & Amortization (CF) was $490,000 in Q4 2019, compared to $490,000 in Q3 2019 and $489,000 in Q2 2019.